ACTIVE SESSION TAPE Biotechnology $386M Cap Quant: HOLD

Why Is Lineage Cell Therapeutics, Inc. (LCTX) Stock Down Today?

Updated Nov 20, 2026 6:20 PM ET · Prev Close $0.82

Pro Workspace
Last Session Price
$0.77 -5.87%
-$0.05 vs $0.82 prior close
Intraday Range
$0.77 – $0.84
Open $0.81
Relative Volume
0.96x Avg
2,037,208 sh
52-Week Range
$0.77 – $1.99
Benchmark Alpha
-2.23% vs SPY
-0.20% vs QQQ
20-Session Trend -22.6%

Session Regime & Catalyst Assessment

68% Signal Conviction
TECHNICAL 68% Driver Weight

Lineage Cell Therapeutics, Inc. Pulling Back 5.87% on 0.96x Relative Volume

Lineage Cell Therapeutics, Inc. (LCTX) is pulling back 5.87% (-$0.05) to $0.77 on 0.96x average session volume. Relative to benchmarks, LCTX is lagging the S&P 500 by -2.23%. 14-day RSI stands at 34.1, keeping momentum in a bearish regime.

NEWS 70% Weight
What Lineage Cell Therapeutics LCTX Said on Its Q3 Earnings Call

Lineage Cell Therapeutics Nyseamerican Lctx has acquired privately held NeuroAirmid Therapeutics, adding an experimental Huntington s disease cell therapy to its clinical pipeline as the company reported a wider third-qu

TECHNICAL 68% Weight
Moving Average Structure: Bearish Alignment

Price ($0.77) trades relative to 20-day SMA ($0.97) and 50-day SMA ($0.97).

Volume Confirmation
MODERATE VOLUME (0.96x) Normal
Institutional participation confirms directional price action.
Composite Catalyst Confidence 68%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

LCTX lagging the S&P 500 by -2.23%
LCTX Session
-5.87%
$0.77
S&P 500 (SPY)
-3.64%
$689.81
Nasdaq 100 (QQQ)
-5.67%
$608.45
Healthcare (XLV)
-0.12%
$177.24
Alpha vs SPY: -2.23% Alpha vs QQQ: -0.20% Alpha vs XLV: -5.75%

Options Flow & Execution Desk

Recent LCTX Catalyst Headlines

Verified Wire

1–3 Day Expected Range & Key Level

54% Follow-Through
Lower Bound
$0.73
Short-term support band
Upper Bound
$0.81
Short-term resistance band
Key Inflection Level
$0.77 (session support)

Monitor volume expansion above 1.5x RVOL around $0.77 (session support) for directional breakout confirmation.

Technical Regime (LCTX)

BEARISH MA TREND
RSI (14)
34.1
Bearish
20-Day SMA
$0.97
Below 20d
50-Day SMA
$0.97
Below 50d
MACD Signal
Bearish
MACD -0.05
ADX (14)
17.4
Weak trend
10d Momentum
-0.25
Soft 10-day momentum

Retail & Crowd Sentiment

Very Bullish
24h Messages
11
1.2x 7d avg
Bullish / Bearish
81.8% / 18.2%
Moderate buzz
Crowd Discussion Digest

A bullish StockTwits message highlights insider buying in $LCTX and $IMDX, suggesting potential positive news in the next six months.

Reddit communities: 1 comment (Neutral)

About Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of …

Sector
Healthcare
Market Cap
$386M
Employees
77

Get Instant LCTX Catalyst Alerts

Receive an email alert when LCTX triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

LCTX Session & Catalyst FAQ

Why is LCTX stock down today?

Lineage Cell Therapeutics, Inc. (LCTX) is pulling back 5.87% (-$0.05) to $0.77 on 0.96x average session volume. Relative to benchmarks, LCTX is lagging the S&P 500 by -2.23%. 14-day RSI stands at 34.1, keeping momentum in a bearish regime.

Is LCTX stock a buy or sell right now?

Today's session carries a 68% catalyst conviction score on 0.96x relative volume (moderate participation). Our multi-factor model currently rates LCTX as HOLD. Review full valuation, quality, and timing signals on the LCTX Buy or Sell Decision Brief →

What is LCTX's intrinsic value and expected trading range?

At $0.77, LCTX's modeled 1-to-3 session range is $0.73 – $0.81, with a key inflection level at $0.77 (session support). Compare current price against multi-year cash flow projections in the LCTX Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for LCTX?

RSI at 34.1 reflects soft below-midline momentum. LCTX trades at $0.77 relative to its 20-day SMA ($0.97) and 50-day SMA ($0.97), reflecting a bearish moving-average structure.

Tradestie Flagship Research & Market Hubs